R2P (p.Arg2Pro) variant of AMH (Anti-Muellerian hormone)

R2P (p.Arg2Pro) in AMH (Anti-Muellerian hormone) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.

R2P (p.Arg2Pro) variant details